Publications

  1. Evans H., Kletzel M., Lawson R., Frankel L., and Hopfer R.: systemic Mycosis Due to Trichosporon Cutaneum. A Report of Two Additional Cases. Cancer 1980; 45:367371.
  2. Kletzel M. and Jaffe Norman: Systemic Hypertension: A complication of Intra-arterial Cis-Diammine-Dichloroplatinum (11) Infusion. Cancer 1981; 47:245-247.
  3. Kletzel M.: Osteosarcoma En Pediatria. Anales Medicos Hosp ABC 1985; 30:3032.
  4. Kletzel M.: Systemic Lupus Erythematous Preceding Acute Lymphoblastic Leukemia. J. Ark. Med. Soc. 1986; 82(11).
  5. Kletzel M., Salmon L.E., Jessurum J.: Plasma Cell Granuloma of the Lung. J. Ark. Med. Soc. 1985; 20:715
  6. Golladay E.S., Mollit D.L., Lang N.P., Berry D.H., Neuberg R., Kletzel M.: Conversion to Resectability by Intra-arterial Infusion Chemotherapy after Failure of Systemic Chemotherapy. J. Of Ped. Surg. 1985; 20:715.
  7. Gollin S.M., Perrot W., Gray B.A., Kletzel M.: Spontaneous Expression of t (11) (q23) in a Patient with Ewing's Sarcoma and t (11:22) (q23; q11). Cancer Genetics and Cytogenetics 1986; 20:331.
  8. Kletzel M., Gollin S.M., Gloster E.S., Jimenez J.F., Golladay E.S., Berry D.H.: Chromosome Abnormalities in Familial Hemophagocytic Lymphohistiocytosis. Cancer 1986; 57(11): 2153-2157.
  9. Hathaway G., Stern C., Kletzel M.: Clinical Problem: Mucositis. J. Association Ped. Onc. Nurses 1986; 23.
  10. Zaatari M.D., Chan W., Kim T., Williams D.L., and Kletzel M.: Malignant Lymphoma of the Skin in Children. Cancer 1987; 59(5): 1040-1045.
  11. Kletzel M., Charlton R., Becton D, Berry D.H.: Cryoprecipitate a Safe Factor VIII Replacement. Lancet 1987; 8541(1): 1093.
  12. Kletzel M., Arnold W.C., Berry D.H.: Paroxysmal Nocturnal Hemoglobinuria Presenting as Recurrent Hemolytic Uremic Syndrome. Clinical Pediatrics 1987; 26(6): 319-20.
  13. Alexander J.E., Woody C.R., Seibert J.J., Kletzel M.: Scurvy: Still with Us. Clinical Pediatrics 1987; 26(11):598.
  14. Mallory S.B., Kletzel M., Turley C.P.: X linked Ichthyosis with Acute Leukemia. Arch Dermatol 1988; 124:2224.
  15. Becton D.L., Kletzel M., Golladay E.S., Hathaway G, Berry D.H.: An Experience with an Implanted Port System in 66 Children with Cancer. Cancer 1988; 61:376-378.
  16. Becton D. L., Kletzel M., Arnold W.C., Berry D.H.: Thrombotic Thrombocytopenic Purpura in an Asplenic Patient with Hereditary Spherocytosis: Failure of Plasmapheresis, Antiplatelet Therapy and Corticosteroids. Amer J Ped Hem/Onc 1988; 10(1): 58.
  17. Advisory Committee of the International Bone Marrow Transplant Registry. Registry report. Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplantation 1989; 4:221-228.
  18. Kletzel M., Miller CH, Becton DL, Chadduck WM, Elser JM: Post Delivery Head Bleeding in Hemophilic Neonates Causes and Management. AJDC 1989; 143:1107-1110.
  19. Kletzel M., Miller CH, Becton DL, Chadduck WM,Elser JM: Hemorragies Craniennes a la Naissance Chez les Enfants Hemophiles. Am. J. Dis. Child. Journal de Pediatrie 1989; 8:78.
  20. Stephenson CA, Kletzel M, Seibert JJ, Glasier CM. Pancreatoblastoma MR Appearance. J Comput Tomogr 1990; 14(3): 492-493.
  21. Sawyer JR, Chadduck WM, Kletzel M. Progression of Chromosome Abnormalities after Radiation Therapy in a Patient with Askin's Tumor. Cancer Genet and Cylogenet, 1990; 47:8994.
  22. Taylor BJ, Chadduck WM, Kletzel M, Rush JE, Moore B. Anencephalic Infants as Organ Donors. The Medical, Legal, Moral and Economic Issues. Ark Med Journal 1990; 87(5): 184-187.
  23. Kletzel M, Beck S, Shock N, Elser J, Burks N. Trimethoprim Sulfamethoxasole (TMP/SMX) Oral Desensitization in HIV Infected Hemophiliacs with a Previous History of Hypersensitivity Reactions. AJDC 1991; 145:1428-1429.
  24. Kletzel M, Becton DL, Berry DH. Single Institution Experience With High Dose Cyclophosphamide, Continuous Infusion Vincristine, Escalating Dose Of VP16213 And Total Body Irradiation With Unpurged Bone Marrow Rescue In Children With Neuroblastoma. Med Ped Onc 1992; 20(1): 6467.
  25. Kletzel M, Elser J, Miller CH, Shock N, Whaley P. Pancreatitis in HIV Positive Hemophiliacs. AIDS Patient Care 1991; 5(6): 280-281.
  26. Hoots WK. Buchanan GR. Parmley RT. Alperin JB. Kletzel M. Sexauer CL. Comprehensive Care For Patients With Hemophilia: An Expanded Role In Reducing Risk For Human Immunodeficiency Virus. Texas Medicine 1991, 87(6): 73-5
  27. Brodsky MC, Casteel HB, Barber LD, Kletzel M, Roloson GJ; Bilateral Iris Tumors in an Immunosuppresed Child. Surv of Ophthal 1991; 36(3): 217-222.
  28. Kletzel M, Kearns GL, Wells TG, Thompson HC. Pharmacokinetics of High Dose Thiotepa in Children Undergoing Autologous Bone Marrow Transplantation. Bone Marrow Trans 1992; 10:171-175.
  29. Jacobs RF, Vats TS, Pappa KA, Chaudrhary S, Kletzel M, Becton DL. Ceftazidine vs. Ceftazidime and Tobramycin in Febrile Neutropenic Children. Infection 21 1993; 4:223-228.
  30. Bortin MM, Horowitz PA, Rimm AA, Sobocinski KA, Zhang MJ, Gale RP.For The Advisory Committee Of The International Bone Marrow Transplant Registry. 1993 Progress Report from The International Bone Marrow Transplant Registry. Bone Marrow Transplantation 1993, 12:97-104.
  31. Redman JF, Kletzel M Cutaneous Vesicostomy with Direct Intravesical Application of Formalin: Management of Severe Vesical Hemorrhage Resulting From High Dose Cyclophosphamide J. Of Urology 1994; 151:1048-1050.
  32. Kletzel M, Olszewski M, Dunn G. Processing Bone Marrow with a Semi-Automated Cell Processor for Pediatric Transplants: A Comparison of Two Buffy Coat Preparation Methods. Journal of Hematotherapy 1994; 3:59-64.
  33. Cohn SL, Hamre M, Kletzel M, Chou P, Radkowski MA. Intraspinal Wilms Tumor Metastases. Cancer 1994; 73:2444-2449.
  34. Kletzel M, Longino R, Danner K, Olszewski M, Moss T. Peripheral Blood Stem Cell Rescue In Children With Advance Stage Neuroblastoma. Advances in Bone Marrow Purging and Processing. Fourth International Symposium 1993 Pp 513-519.
  35. Sawyer JR, Crussi FG, Kletzel M. Pericentric Inversion (2) (P 15 Q 35) In an Alveolar Rhabdomyosarcoma. Cancer Genetics and Cytogenetics, 1994, 78(2):214-8.
  36. Braun MC, Cohn RA, Kletzel M. Nephrotic Syndrome Accompanying Familial Hemophagocytic Syndrome. J Of Ped Hem Onc, 1996 18(2) 195-197
  37. O’Reilly R, Cheung NK, Bowman L, Castle V, Hoffer F, Kapoor N, Kletzel M, Lindsey K, Shamberger R, Tubergen D. NCCN Pediatric Neuroblastoma Practice Guidelines. Oncology 1996, Vol 10(12) 1813-1822.
  38. Hoover M, Kletzel M, Morgan ER. Prior Fungal Infection Is Not A Contraindication To Bone Marrow Transplant at In-Patients With Acute Leukemia. Med Ped Onc, 1997, 28:268-273.
  39. Katzenstein H, Morgan E, Olsewski M, Danner Koptik K, Kletzel M. Haploidentical Related Umbilical Cord Blood Stem Cell Transplant In A Child With Acute Non-Lymphoblastic Leukemia. Bone Marrow Transplant 1997 19,765-769.
  40. Kletzel M, Haut P, Atlas M, Olsewski M, Danner Koptik K, Hubble M. Red Cell Depletion Of Umbilical Cord Blood (UCB). Comparison between Unmanipulated and Red Cell Depleted By Ficoll-Paque Density Gradient Separation after Cryopreservation. J Of Hematotherapy 1997 6; 269-272
  41. Cohn L, Moss TJ, Hoover M, Katzenstein HM, Haut PR, Morgan ER, Green AA, Kletzel M. Treatment Of Poor Risk Neuroblastoma Patients With High -Dose Chemotherapy And Autologous Peripheral Stem Cell Rescue. Bone Marrow Transpl 1997 20, 543-551
  42. Kletzel M. Abella EM, Sandler ES, Williams LL, Ogden AK, Pollock BH, Wall DA. Thiotepa and Cyclophosphamide with Stem Cell Rescue as Consolidation Therapy for Children with High Risk Neuroblastoma. A Phase I/II Study of the Pediatric Blood and Bone Marrow Transplant Consortium. J Of Ped Hem Onc 1998 20(1) 49-54.
  43. Applegate GL, Kletzel M. E Morgan, Johnson P, Danner K, Marymount M. Outpatient Total Body Irradiation Prior To Bone Marrow Transplantation in Pediatric Patients: Feasibility Analysis. Bone Marrow Transpl 1998 21: 651-652.
  44. Kletzel M, Morgan E, Frader J. Ethical Issues in Stem Cell Transplantation. J Of Hemathoherapy 1998 Vol 7, (3) 197-203.
  45. Haut PR, Cohn S, Morgan E, Hubbell M, Danner-Koptik K, Olsewski M, Kletzel M. Efficacy Of Autologous Peripheral Stem Cell (PBSC) Harvesting And Engraftment Following Ablative Chemotherapy In Pediatric Patients. Biology of Blood and Marrow Trans 1998 4: 38-42.
  46. Kletzel M, Longino R, Rademaker AW, Danner-Koptik KE, Olszewski M, Morgan ER. Peripheral Blood Stem Cell Transplantation In Young Children: Experience With Harvesting, Mobilization And Engraftment. Pediatr Transplantation 1998:2; 191-196.
  47. Pirich L, Haut P, Morgan E, Marymount MA, Kletzel M. Total Body Irradiation, Cyclophosphamide And Etoposide With Stem Cell Transplant As Treatment For Infant Acute Lynphocytic Leukemia. Med Ped Onc 1999 32:1-6
  48. Scholl PR, O'Gorman MRG, Pachman LM, Haut P, Kletzel M. Correction Of Neutropenia And Hypogammaglobulinemia In X Linked Hyper IGM Syndrome By Allogeneic Bone Marrow Transplantation. Bone Marrow Transp 1998 22, 1215-1218.
  49. Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn SL. Clinical Impact And Prognostic Value Of Metaiodobenzylguanidine Imaging In Children With Metastatic Neuroblastoma. J Peadiatr Hem Onc 1999 21(1) 13-18.
  50. Laver JH, Klann R, Kletzel M, Moss TJ Mageed AA, Willingham M, Gross AJ, Kemhead J. Comparison Of The Presence Of Tumor Cells In Purged Marrow Versus Peripheral Blood In Stem Cell Grafts In Neuroblastoma. Cancer Research Ther and Control 1999. Vol 9 Pp25-30
  51. Walterhouse DO, Hoover ML, Marymount MA, Kletzel M. High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Metastatic Rhabdomyosarcoma: The Experience at Children’s Memorial Hospital. Med Ped Onc 1999 32 88-92
  52. Flores-Stadfler EM, Gonzalez-Crussi F, Greene M, Thangavelu M, Kletzel M, Chou PM. Indeterminate-Cell Histiocytosis: Immunophenotypic And Cytogenetic Findings In An Infant Med Peditr Oncol 1999 32:250-254
  53. Kletzel M, Olszewski M, Danner-Koptik K, Coyne K, Haut PR. Red Cell Salvage And Re-Infusion In Pediatric Bone Marrow Donors. Bone Marrow Transp 1999 24 Pp 385-388.
  54. Kletzel M, Haut PR, Olszewski M, Figuerres E. Analysis Of Parameters Affecting Engraftment In Children Undergoing Allogeneic Bone Marrow Transplants. 1999 Cytotherapy Vol 1 (5) 417-422.
  55. Pan W, Haut PR, Olszewski M, Kletzel M. Two-Day Collection and Pooling of Peripheral Blood Stem Cells with a Semi automated Density Gradient Cell Separation. J Hematho and Stem Cell Research 1999 8:561-564.
  56. Shaw PH, Haut PR, and Olsewski M, Kletzel M, Hematopoietic Stem Cell Transplantation Using Unrelated Cord Blood Versus Matched Sibling Marrow In Pediatric Bone Marrow Failure Syndromes: One Centers Experience. Pediatr Transplantation 1999 3:315-321.
  57. Figuerres E., Haut PR, Olszewski M, Kletzel M Analysis Of Parameters Affecting Engraftment In Children Undergoing Autologous Peripheral Blood Stem Cell Transplants. Bone Marrow Transpl 2000 25 (6), 583-588
  58. Levine JE, Wiley J, Kletzel M, Yanik G, Hutchinson RJ, Neudorf S. Cytokine Mobilized Allogeneic Peripheral Blood Stem Cell Transplants In Children Result In Rapid Engraftment And High Incidence Of Graft Vs. Host Disease. Bone Marrow Transp 2000 25(1), 13-18
  59. Kletzel M, Meitar D, El –Yousef M, Cohn SL. Gastrointestinal Relapse In An Adolescent With Acute Lymphoblastic Leukemia. Mimicking Acute Graft vs. Host Disease Following an HLA- Matched Sibling Hematopoietic Stem Cell Transplant. Med and Ped Hem Onc 2000 34:287-289
  60. Yu LC, Wall DA, Chan KW, Grayson G, Kletzel M. Unrelated Cord Bloods Transplant Experience By The Pediatric Blood And Marrow Consortium 2001 Ped Hematology And Oncology 18:235-245
  61. Shaw PH, Cohn SL, Morgan ER, Kovarik P, Haut PR, Kletzel M, Murphy SB Natural Killer Cell Lymphoma: Report Of Two Pediatric Cases, Therapeutic Options And Review Of The Literature. 2001 CANCER Vol 91(4) Pp 642-646
  62. Shaw P. Mancini AJ McConnell JP, Brown D, Kletzel M. Treatment Of Congenital Erytropoietic Porphiria In Children With Allogeneic Stem Cell Transplantation: A Case Report And Review Of The Literature. Bone Marrow Transplantation 2001 (27) 101-105
  63. Figuerres E, Olszewski M, Kletzel M. A Flow Cytometric Technique to Detect Platelet Engraftment Following Pediatric Stem Cell Transplants Using Thiazole Orange. 2001 Cytotherapy Vol3 (4) 277-283
  64. Gonzalez-Ryan L, Haut P, R, Coyne K, Van Syckle K, Duerst R, Haro D, Kletzel M. Developing A Pediatric Outpatient Transplantation Program. The Children’s Memorial Hospital Experience. 2001 Frontiers In Bioscience 6: 1-5
  65. Haut PR, Kovarik P, Shaw PH, Walterhouse D, Jenson HB, Kletzel M. Detection Of EBV DNA In The Cord Blood Donor For A Patient Developing Epstein-Barr Virus Associated Lymphoproliferative Disorder Following Mismatched Unrelated Umbilical Cord Blood Transplantation 2001 Bone Marrow Transplantation 27 Pp 761-765
  66. Shaw P, Olsewski M, Kletzel M Expansion Of Megakaryocyte Precursors And Stem Cells From Umbilical Cord Blood CD34+ Cells In Collagen And Liquid Culture Media 2001 Hematotherapy And Stem Cell Research .10(3) 391-403
  67. Green DM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D’Angiuo GJ, Perlman E, Donaldson M. Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer P, Coccia P, Kletzel M, Thomas PRM, Macklis R, Tomlison G, Huff V. Treatment With Nephrectomy Only For Small Stage I Favorable Histology Wilms Tumor. A Report from the National Wilms Tumor Study Group. 2001 JCO 19:3719-3724
  68. Katzenstein HM, Rigsby C, Shaw PH, Mitchell T, Kletzel M. Novel Therapeutic Approaches in the Treatment of Children with Hepatoblastoma. 2002 J of Pediatric Hem Onc.
  69. Wang LJ, Chou P, Gonzalez –Ryan L, Haut PR, Huang W, Kletzel M. Evaluation Of Mixed Chimerism In Pediatric Patients With Leukemia After Allogeneic Stem Cell Transplantation By PCR Quantitative Analysis Of Variable Number Tandem Repeat And Testis Determination Gene. 2002 Bone Marrow Transplantation 29(1); 51-
  70. Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Kalapurakal JA, Shore RM, Bardo DME, Schmoldt J, Rademaker AW And Cohn SL. Treatment Of High Risk Neuroblastoma With Triple Tandem High Dose Therapy And Stem Cell Rescue: Results Of The Chicago Pilot II Study. 2002 JCO 20:2284-2292
  71. Kletzel M, Olzewski M, Huang W, Chou PM Utility Of WT1 As A Reliable Toll For The Detection Of Minimal Residual Disease In Children With Leukemia. 2002 Pediatric And Developmental Pathology 5,269-275
  72. Venkateswaran L, Duerst R, Haut PR, Chou PM, Kletzel M. Letter To The Editor Bone Marrow Necrosis Associated With Acute Myelogenous Leukemia Following Stem Cell Transplantation. 2002 Med And Ped Oncol 38: 148-149
  73. Haut PR, Gonzalez-Ryan L, Wang Lj, Olszewski M, Morgan E, Kletzel M. Induction Of Graft Vs. Leukemia Effect Following Unrelated Cord Blood Transplantation: Proof Of Principle 2002 Ped Transplant 6:348-351
  74. Warwik AB, Zhang MJ, Shuster JJ, Horowitz MM, Camita BM, Et Al. Chemotherapy Vs HLA Identical Sibling Bone Marrow Transplantation (BMT) For Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL) In First Remission. 2002 Blood.
  75. Katzenstein HM, Kletzel M, Reynolds M, Superina R, Gonzalez Crussi F. Letter To The Editor: Metastatic Malignant Rhabdoid Tumor Of The Liver Treated With Tandem High Dose Therapy And Autologous Peripheral Blood Stem Cell Rescue. 2003 Med Pediatr Oncol 40; 199-201
  76. Hoepfner Sabine, Haut PR, O’Gorman M, Kletzel M. Rapid Immune Reconstitution Following Autologous Stem Cell Transplantation In Children: A Single Institution Experience. 2003 Bone Marrow Transplantation 31(4) 285-290
  77. Chou P, Olszewski M, Huang W, Silva M, Kletzel M. Platelet Chimerism By Polymerase Chain Reaction (PCR) Utilizing Variable Number Of Tandem Repeats (VNTRs) In Allogeneic Stem Cell Transplant In Children: A Novel Approach To Full Chimerism Analysis. 2003 Bone Marrow Transplantation 32 (8),825-828
  78. Murphy SB, Morgan ER, Katzenstein HM, Kletzel M. Results Of Little Or No Treatment For Lymphocyte Predominant Hodgkin’s Disease In Children And Adolescents.2003 J Pedtr Hematology Oncology 25( 9); 684-687
  79. Jacobsohn D, Schechter T, Thorman K, Duerst R, Kletzel M. Eosinophilia Is A Predictor for the Development of Chronic GVHD in Children. 2004 Transplantation Vol 77(7) Pp 1096-1100.
  80. Jacobsohn DA, Karan ME, , Scholl PR, Melin-Aldana H, O’Gorman MRG Duerst R, , Kletzel M. Non-Myeloablative Hematopoietic Stem Cell Transplant For X-Linked Hyper Immunoglobulin M Syndrome With Cholangiopathy. 2004 Pediatrics Vol 113(2) 122-127
  81. Jacobsohn D, Duerst R, Tse W, Kletzel M. Reduced Intensity Hematopoietic Stem Cell Transplantation For Treatment Of Non-Malignant Diseases In Children 2004 Lancet Vol 364 Pp156-162
  82. Campbell AD, Morgan E, Reynolds M, Seshadri R, Geissler G, Cohn SL, Marymount M, Kalapurakal J, Haut PR, Duerst R, Kletzel M. Autologous Peripheral Stem Cell Rescue For Children With Relapsed Wilms Tumor: The Children’s Memorial Experience. 2004 JCO Vol. 22 (14) 2885-2890
  83. Coquillard G, Lau M, Kletzel M, Rodriguez-Marino SG. Identification of Two Novel Pseudogenes, HLA-COQ and HLA- DEL, With Sequence Homology to Human and Other Primate MHC Class I A: Ancestral Haplotype in the Philipino Population. 2004 Human Immunol 65 Pp 665-673
  84. Katzenstein H, Cohn SL, Bardo ME, Shore RM, Haut PR, Olszewski M, Schmoldt J, Liu D, Rademaker AW, Kletzel M. Prognostic Value Of Metaiodobenzylguanidine And Bone Scintigraphy And Expression Of Tyrosine Hydroxylase In High Risk Neuroblastoma. 2004 JCO 22(19) Pp 3909-3915
  85. Kretchmar CS, Kletzel M, Murray K, Thomer P, Joshi V, Marcus R, Smith EI, London WB, Castleberry R. Response To Placlitaxel, Topotecan And Topotecan-Cyclophosphamide In Children With Untreated Disseminated Neuroblastoma Treated In An Upfront Phase II Investigational Window: A Pediatric Oncology Group Study. 2004 JCO 22(20) pp4119-4126
  86. Jacobsohn DA, Hewlett B, Ranalli M, Seshadri R, Duerst R, Kletzel M. Outcomes Of Unrelated Cord Blood Transplants And Allogeneic-Related Hematopoietic Stem Cell Transplants In Children With High Risk Acute Lymphoblastic Leukemia. 2004 Bone Marrow Transplant 34,901-907
  87. Freeman AF, Jacobsohn DA, Shulman ST, Bellini WJ, Jaggi P, De Leon G, Keating GF, Kim F, Pachman LM, Kletzel M, Duerst RE. A New Complication of Stem Cell Transplantation: Measles Inclusion Body Encephalitis. Pediatrics 2004 114(5) 657-660
  88. Olszewski M, Huang W, Chou PM, Duerst R, Kletzel M. Wilms Tumor Gene (WT1) In Hematopoiesis: A Surrogate Marker of Cell Prolipheration as a Possible Mechanism of Action? 2005 Cytotherapy Vol 7 (1) Pp 57-61
  89. Kletzel M, Pirich L, Haut P, Cohn RA. Comparison of Tc-99 Measurement of Glomerular Filtration Rate versus Calculated Creatinine Clearance to Assess Renal Function Pre-Transplant in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. Pediatr Transplantation 2005:9:584-588
  90. Trobaugh-Lotrario A, Kletzel M, Quinones RR, Mcgavran L, MA, Proycheva, Hunger SP, Malcolm J, Schissel D, Hild E, Giller RH. Monosomy 7 Associated With Pediatric Myeloid Leukemia (AML) And Myelodysplastic (MDS): Successful Management By Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). 2005 Bone Marrow Transplantation 35,143-149
  91. Long X, Olszewski M,Huang W, Kletzel M. Neural Cell Differentiation In Vitro From Adult Human Bone Marrow Mesenchymal Stem Cells.2005 Stem Cells And Develop 14; 65-69
  92. Oyama Y, Craig RM, Trainor AE, Quikley K, Statkute L, Halverson A, , Brush M, Verda L, Kowalska B , Kronsnja N, Kletzel M, Whitington PF, Burt RK. Autologous Hematopoietic Stem Cell Transplantation in Patients with Refractory Croh’s Disease. 2005 Gastroenterology 128; Pp 552-63
  93. Kletzel M, Hewlett Brad. Pediatric Transplantation: Results in Solid Tumors. Current Hematology Reports 2005 July 4(4) Pp260-69
  94. Jacobsohn D, Hewlett B, Morgan E, Tse W, Duerst R, Kletzel M. Favorable Outcome Of Infants With Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation. 2005 Biology Of Blood And Marrow Transplant 11(12) 999-1005
  95. Kletzel M., Jacobsohn D, Tse William, Duerst R. Reduced Intensity Transplants (RIT) In Pediatrics. A Review. 2005 Ped Transpl 9 (suppl 7) pp63-70
  96. Kletzel M. Jacobsohn D, Duerst R... Pharmacokinetics of a Test Dose of Intravenous Busulfan Guide dose Modifications to Achieve an Optimal Area Under The curve of a Single Daily Dose of Intravenous Busulfan in Children Undergoing a Reduced intensity Conditioning Regimen with Hematopoietic Stem cell Transplantation. Biology Of Blood And Marrow 2006 Vol 12(4) pp472-479
  97. Browning B, Thorman K, Seshadri R, Duerst R, Kletzel M. Weight Loss and Reduced Body Mass Index: A critical Issue in Children with Multiorgan Chronic Graft-Versus-Host Disease. Bone Marrow Transplantation 2006 1-7
  98. Browne M, Kletzel M, Seshadri R, Cohn SL, Reynold M. Excellent Local Tumor Control Regardless Of The Extent Of Surgical Resection Following Treatment On The Chicago Pilot II Protocol For Neuroblastoma J Of Peds Surgery. 2006 41,271-276
  99. Olszewski M, Chou PM, Huang W, Tallman S, Kletzel M. Correlation Of Minimal Residual Disease (MRD) by Assessing Wilms’ Tumor Gene Expression And Engraftment By Variable Number Tandem Repeats In Children With Leukemia Post Hematopoietic Stem Cell Transplantation J of Pediatric and Developmental Pathology 2006 Vol. 9 (3) pp203
  100. Kletzel M. Why Target the WT1 gene? Blood 2006 Vol. 1(12) Pp 4578-79
  101. Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Thomas PRM, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coopes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Green DM. Treatment of Anaplastic Histology Wilms Tumor: results from the Fifth National Wilms Tumor Study JCO 2006 24(15) 2352-8
  102. Melin-Aldama H, Thormann K, Duerst R, Kletzel M, Jacobsohn DA. Hepatitis pattern of Graft Vs Host Disease in Children. Pediatr Blood and Cancer 2006 pp1-5
  103. Green DM, Malogolowkin M, Cotton C, Breslow NE, Perlman E, Miser J, Ritchy M, Thomas PRM, Grundy PE, D’Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coopes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tiomlison G, Huff V, Newbury R, Weeks D. Treatment of Wilms Tumor Relapsing After Initial Treatment with Vincristine and Actinomycin D. a Report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2007; 48 (5):493-499
  104. Burke MJ., Walterhouse D, Jacobsohn D, Duerst R, Kletzel M. Tandem High Dose Chemotherapy with Autologous Peripheral Hematopoietic Progenitor Cell rescue as Consolidation for High risk Ewing’s Sarcoma: The experience at Children’s Memorial Hospital. Pediatr Blood and Cancer 2007 49(2) 196-8
  105. Anderson EJ Guzman-Cotrill JA, Kletzel M , Thormann K , Sullivan C,Zheng X, Katz BZ. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy.Pediatr Transplant. 2008 Mar; 12(2): 219-27.
  106. Schneiderman J, Thorman K, Charrow J, Kletzel M. Correction of Enzyme Levels with Allogeneic Hematopoietic Progenitor Cell Transplant in Niemann Pick Type B. Pediat Blood and Cancer 2007 49(7) 987-89
  107. Zheng X, Lu X, Erdman D, Anderson EJ, Catdung T, Guzman-Cottrill JA, Kletzel M, Katz BZ. Identification of Adenovirus from High Risk Stem Cell Transplant Recipients and Controls. J of Clin Micro 2008 46(1) 317-20
  108. Brandao LR, Kletzel M, Boulad F, Kurtzberg J, Maloney K, Fligman I, Sisin CP, Di Michele D. A Prospective Longitudinal Multicenter Study of Coagulation in Pediatric Patients Undergoing Pediatr Blood Cancer. 2008 Jun; 50(6):1240-6.
  109. Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PRM, Grundy PE, D’Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D. Treatment of Wilms Tumor Relapsing After Initial Treatment with Vincristine, Actinomycin D, and Doxorubicin. A Report from the National Wilms Tumor Study Group. Pediatrr Blood and Cancer 2008; 50:236-241.
  110. Dubowy R, Graham M, Hakami N, Kletzel M, Mahoney D, Newman E. Ravindranath Y. Sequential Hydroxyurea and Intravenous Cytosine Arabinoside in Refractory Childhood Acute Leukemia. A Pediatric Oncology group Phase 1 Study. J Pediatr Hematol Oncol. 2008 May;30(5):353-357.
  111. Zage PE, Kletzel M, Murray K, Marcus R, Joshi V, Castleberry R, Zhang Y, London W, Kretchmar C. Outcomes of the POG 9340/9341/9342 Trials for Children with High Risk Neuroblastoma. Pediatr Blood and Cancer 2008; 51:747-753
  112. Tse WT, Duerst R, Schneiderman J, Chaudhury S, Jacobsohn D, Kletzel M. Age Dependent Pharmacokinetic Profile of Single Daily Dose Intravenous Busulfan in Children Undergoing Reduced Intensity Conditioning Stem Cell Transplantation. Bone Marrow Transplant. 2009 Aug; 44(3):145-56. Epub 2009 Apr 6.
  113. Rosenfeld A, Rademaker A, Schaefer C, Fouts M, Duerst R, Jacobsohn D, Kletzel M. Goldman S. Phase II Prospective Study of Sequential Myeloablative Chemotherapy with Hematopoietic Stem cell Rescue (HSCR) for the Treatment of Selected High Risk and Recurrent CNS Tumors. J of Neuro-Oncology. 2010 Apr;97(2):247-55
  114. Pulsip[her MA, Boucher KM, Wall D, Frangoul H. Duval M, Goyal RK, Shaw PJ, Haight AE, Grim;ey M, Grupp SA, Kletzel M, Kadota R. Reduced Intensity allogeneic Transplanatation in Pediatric Patients Ineligible for Myeloabkative Therapy. Results from the Pediatric Blood and Marrow Transplant Consortium (PBMTC) ONC 0313. Blood 2009; 114:1429-1436
  115. High WT1 gene expression before Hematopoietic Stem Cell Transplant in Children with Acute Myeloid Leukemia Predicts Poor Outcome. Br J of Haematol 2009 Sept 1:46 (6) 669-74. Epub 2009 Jul 23
  116. Shamberger RC, Anderson JR, Breslow NE, Perlman E, Beckwith JB, Ritchey MI, Haase GM, D”Angio GJ, Donaldson M, Grundy PE, Coopes MJ, Malogolowkin M, Shearer P,Coccia P, Kletzel M, Thomas PRM, Macklis R, Tomlnison G, Huff V,Newbury R, Weeks D, Green DM. Longh Term Outcome of Infants with Very Low Risk Wilms Tumor Treated with Surgery Alone on National Wilms Tumor Study –2010 Ann of Surg 251 (3) 555-558
  117. Wall DA, Chan KW, Niedler ML, Hayashi RJ, Yeager AM, Kadota R, Przepiorka D, Mezzi K, Kletzel M; Safety and Efficacy, and pharmacokinetics of Intravenous Busulfan in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplant for the Pediatric Blood and Marrow Consortium. 2010 Pediatr Blood and Cancer 54;291-298
  118. Mc Neer J, Kletzel M, Rademaker A, Schaefer C, O’Day, Alford K, Duerst R, Jacobsohn D. Early Elevation of C- Reactive Protein Correlates With Severe Infection and Non-Relapse mortality in Children Undergoing Allogeneic Stem cell Transplantation. 2010 BBMT 16(3) 350-7
  119. Schneiderman J, Jacobsohn DA, Collins J, Thorman K, Kletzel M. The Use of Fluid Boluses to Safely Perform Extracorporeal Photopheresis (ECP) in Low-weight Children: A novel approach. J of Clinical Apheresis 2010 ;25(2):63-69
  120. Kakodkar NC, Peddinti R, Kletzel M, Tian Y, Guerrero LJ, Udevia SD, Geary D, Chelnski A, Yang Q, Salwen HR, CohnSL. The Quinoloxine Anti-Tumor Agent (R+)XK469 Inhibits Neuroblasoma Tumor Growth. Pedatr Blood and Cancer 2011 Jan; 56(1); 164-7.
  121. Andolina JR, Kletzel M, Tse WT, Jacobsohn DA, Duerst RE, Shneiderman J, Helenowski I, Rademaker A, Chaudhury S. Allogeneic hematopoietic Stem Cell Transplantation in Pediatric Myelodysplastic Syndromes: Improved Outcomes for The Novo Disease. Pediatr Transplant 2011 May 15 (3): 334-43
  122. Thakar MSKurre P, Storb R, Kletzel M, Frangoul H, Pulsipher M, Laisenring W, Flowers ME, Sandmaier BM, Woolfey A, Kiem H-P. HLA Matched Unrelated Donor Cell Transplantation for Fanconi’s Anemia Patients Using Fludarabine and Low Dose Total Body Irradiation. Bone Marrow Transplantation 2011 Jan 56(1): 164-7
  123. Browning B, Thormann K, Donaldson A Halverson T, Shinkle M, Kletzel M. Busulfan Dosing in Children with BMIs>85% Undergoing HSCT: Anew Optimal Strategy. Biol Blood Marrow Transplant 2011 Sept;1 7(9):1383-8
  124. Chaudhury S, Hormaz L, Mohammad S, Lokar J, Ekong U, Alonson EM, Wainwright M, Kletzel M, Whitington P. Liver Transplantation Followed by Allogeneic Peripheral Blood Stem Cell Transplantation for Atypical Mevalonic Aciduria.. Am J Transplantation 2012 Jun;12(6):334-43
  125. Granger M, Grupp SA, Kletzel M, Kretchmar C, Naranjo A, London WB, Diller L. Feasibility of a Tandem Autologous Peripheral Blood Stem Cell Transplant Regimen for High Risk Neuroblastoma in a cooperative Group Setting: A Pediatric Oncology Group Studt: A report from The Children’s Oncology Group. 2012 Pediatr Blood and Cancer 59; 902-907
  126. Kletzel M, Huang W, Olszewski M, Khan S. Validation of Chimerism in Pediatric Recipients of Allogeneic Stem Cell Transplantation (HSCT) a Comparison Between Two Methods: Real-Time PCR (qrt-PCR) vs. Variable Tandem Repeats PCR (VNTRs) Chimerism. 2012 Dec 13;4(1). Epub PMID:23238335 2013 4:1 pp1-9
  127. Hale GA, Arora M, Ahn KW, He W, Cammita B, Bishop MR, Bitan M, Cairo M, Chan K, Childs RW, Copelan E, Davis SM, Diaz Perez MA, Doyle JJ, gale RP, Gonzalez Vicent M, Horn BN, Hussein AA, Jodele S, Kamani NR, Kasow KA, Kletzel M, Lazarus HM, Lewis VA, Myers KC, Olsson R, Pulsipher M, Qayed M, Sanders JE, Shaw PJ, Soni S, Stiff P, Statdauer EA, Ueno NT, Wall DA, Grupp SA. Allogeneic Hematopoietic Cell Transplantation for Neuroblastoma: The CIBMTR Experience. BMT 2013 Aug; 48(8) 1056-64
  128. Seif AE, Naranjo A, Baker DL, Bunin NJ, Kletzel M, Kretchmar CS, Maris JM, McGrady PW, von Allmen D, Cohn SL, London WB, park JR, Diller LR, Grupp AS. A pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma: Children’s Oncology Group Study ANBL00P1 Bone Marrow Transplantation 2013 jul;48(7):947-52 PMCID: PMC3638062
  129.  Kletzel M. Sindromes Mielodisplasticos en Pacientes Pediatricos. Revista de Hematologia 2013 Vol 14(1) 11-13
  130. Danner Koptik K, Kletzel M, Dilley K . Exostoses as a Long Term Sequela After Pediatric Hematopoietic Progenitor Cell Transplantation (HPCT): Potential Causes and Increase Risk of Secondary Malignancies from The Ann and Robert H. Lurie Children’s Hospital of Chicago 2013 BBMT Aug; 19(8)1267-70 Epub 2013 may 28 PMID 23721826.
  131. Kletzel M. Comment on: Consolidation Treatment for High Risk Solid Tumors in Children with Myeloablative Chemotherapy and Autologous Hematopoietic Progenitor Stem Cell Transplantation. Revista Bras Hematol Hemother 2013; 35(5) ; 309-310 PMCID: PMC383230
  132. S Khan, M Olszewski, M Kletzel Juvenile Myelo-Monocytic Leukemia (JMML): No Effect of Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF) on Wilms Tumor Gene (WT1) by Nested Polymerase Chain Reaction (nPCR) and Flow Cytometry. Advances in Bioscience and Biotechnology, 2014, 5, 155-159
  133. Bitan M, He W, Zhang MJ, Abdel-Azim H, Fakhreddine Ayas M, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, J Horan JT, Jodele S, Kitko CL, Schultz KR, Kletzel M, Kasow KA, Lehmann LE, Mehta PA, Shah N, Pulsipher MA, Prestidge T, Seber A, Shenoy S, WoolfreyAE, Yu LC, and Davies SM.Transplantation for Children with Acute Myeloid Leukemia: A Comparison of Outcomes with Reduced Intensity and Myeloablative Regimens. 2014 Jan Blood
  134. Martin A, Schneiderman J, Helenowski IB, Morgan E, Dilley K, Danner –Koptik K, Hatahet M, Shimada H, Cohn SL, Kletzel M, Hijiya N. Secondary Malignant Neoplasms after High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Neuroblastoma. Pediatr Blood Cancer. 2014 Mar 14.
  135. Kletzel M , Powers K, Hayes M. Scurvy: A new problem for Patients with Chronic Graft vs. Host Disease Involving Mucous Membranes; and Easy Problem to Resolve. Pediatric Transplantation. 2014:18: 524-526
  136. Kletzel M, Chou P, Olszewski M, Rademaker AW, Khan S. Expression of Wilms’ Tumor Gene (WT1) in Patients with High Risk Neuroblastoma: A Complementary Marker to Tyrosine Hydroxylase (TH) Gene Expression for Detection of Minimal Residual Disease (MRD) Translational Pediatrics2015;4(3):219-225
  137. Ward J, Kletzel M,Duerst R, Fuleihan R, Chaudhury S, Schneiderman J, Tse T. Single Daily Busulfan Dosing for Infants with Non-Malignant Diseases Undergoing Reduced Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell Transplantation accepted BBMT 5/2015
  138. Broglie L, Helenowski I, Dilley K, Schneiderman J, Tse W, Duerst R, Kletzel M, Morgan E, Hijiya N, Chaudhury S. Long term Follow up of Children with Chronic Myeloid Leukemia After Hematopoietic Stem Cell Transplantation and Tyrosine Kinase Inhibitor Therapy. 2015 Leukemia Lymphoma
  139. Zahler S, Smith R, Ricci A, Morris E, Harrison L, Van de Ven C, Fabricatore S, Wolownik K, Cooney-Qualter E, Baxter-Lowe LA, Militano O, Kletzel M, Cairo MS. Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Targeted Consolidation Immunotherapy with Gentuzumab Ozogamicin in Children and Adolescents with CD33+Acute Myeloid Leukemia. Submitted July 2015.
  140. Bartelink IH, Lalmohamed A, van Reij EML, Dvorak CC, Savic RM, Zvaeling J, Bredius RGM, Egberts ACG, Bierings M, Kletzel M, Shaw PJ, Nath CE, Hempel G, Ansari M, Krajinovic M, Duval M, Keiser R, Bittencort T, Gungor T, Wynn RF, Veys P, Cuvelier GDE, Marktel S, Chiesa R, Cowan MJ, Slatter MA, Stricherz MK, Jennisen C, Long-Boyle JL, Boelens JJ. Busulfan Exposure Predicts Event free Survival after Hematopoietic Cell Transplantation in Children and Young Adults: A multicenter retrospective Pharmacodynamic Cohort Analysis. July 2015
  141. Armstrong AE, Smyth E, Helenowski IB, Tse WT, Duerst RE, Schneiderman J, Kletzel M, Chaudhury S. The Impact of High Resolution HLA-A,-B,-C and DRB1 on Transplant- related Outcomes in Single –unit Umbilical Cord Blood Transplantation in Pediatric Patients. July 2015 BBMT
  142.  Curi A, Duerst R, Badke C, Bell J, Chaudhury S, Kletzel M, Schneiderman J, Tse W, Muller W, Hijiya N. Intravenous Pentamidine for Pneumocystis jiroveci Pneumonia Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Patients submitted BMT August 2015

 

 

 

 

 

 

 

 

Morris Kletzel

Professor

 

 

  • : 312-227-4090    
  • : (312) 227-9756     
    • DEPARTMENTDepartment of Pediatrics Hematology, Oncology,
      Stem Cell Transplantation and Neuro-Oncology Northwestern
      University Feinberg School of Medicine
    • COUNTRY USA